Found 0 matching trials
Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy PHASE4 Study objective is to demonstrate that anticoagulation with the direct fact...
Show More Location
Montefiore Medical Center
Learn More & Join Trial
Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion PHASE3 A study for patients with abnormal heart rhythm (atrial fibrillation) who n...
Show More Location
Multiple Locations
Learn More & Join Trial
Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device PHASE4 Heart failure is a world epidemic. LVADs are increasingly used as they have...
Show More Location
University of Chicago
Learn More & Join Trial
Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular Carcinoma N/A As key biomarkers in HCC, AFP and PIVKA-II reflects biological features of ...
Show More Location
Multiple Locations
Learn More & Join Trial
Analysis of the Potential Savings of Rivaroxaban Events Versus Vitamin K Antagonists Events N/A The main objective of this project is to evaluate savings in direct costs a...
Show More Location
Multiple Locations
Learn More & Join Trial
Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer NA HCC surveillance is currently limited by underutilization and the suboptima...
Show More Status
Enrolling By Invitation
Location
Faculty of Medicine Siriraj Hospital
Learn More & Join Trial
Randomized Controlled Clinical Trial to Investigate Effects of Vitamin K2 in COVID-19 NA Coronavirus disease 2019 (COVID-19) is caused by the severe acute respirato...
Show More Location
Canisius Wilhelmina Hospital
Learn More & Join Trial
Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events PHASE2 Venous thromboembolism affects around 10 million people per year worldwide,...
Show More Location
Instituto Mexicano Del Seguro Social
Learn More & Join Trial
PIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular Carcinoma N/A The goal of this cross-sectional observational study is to evaluate the rel...
Show More Location
Tanta University Hospitals
Learn More & Join Trial
Surveillance Study for HCC by Combining Biomarkers With Imaging (ALDUS) N/A This study is intended to be a prospective observational study at multiple ...
Show More Location
Graduate School of Medicine and Faculty of Medicine, The University of Tokyo
Learn More & Join Trial